SCHEMBL1721778

SCHEMBL1721778

CCCON=C(C)C(=O)OCC

nearest known ligand 0.48

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.48
GLO1 Q04760 1/20 0.39
ALDH1A1 P00352 6/20 0.39
LMNA P02545 1/20 0.39
HSD17B10 Q99714 1/20 0.39
NPSR1 Q6W5P4 1/20 0.35
TSHR P16473 4/20 0.34
ALOX15 P16050 1/20 0.33
MGAM O43451 1/20 0.33
GAA P10253 1/20 0.33
SI P14410 1/20 0.33
MGAM2 Q2M2H8 1/20 0.33
THRB P10828 1/20 0.33
EGLN1 Q9GZT9 1/20 0.33
SOAT1 P35610 1/20 0.33
FAAH O00519 2/20 0.32
CYP2D6 P10635 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10417779 0.81 GLO1 (0.41) MAPTGLO1ALDH1A1LMNAHSD17B10
SCHEMBL10417780 0.81 GLO1 (0.41) MAPTGLO1ALDH1A1LMNAHSD17B10
SCHEMBL5797996 0.77 MAPT (0.34) MAPTGLO1ALDH1A1LMNAHSD17B10
SCHEMBL5802121 0.77 PTGS2 (0.34) ALDH1A1LMNA
SCHEMBL5802118 0.77 PTGS2 (0.34) ALDH1A1LMNA
SCHEMBL23635709 0.77 MAPT (0.53) MAPTGLO1ALDH1A1LMNAHSD17B10
SCHEMBL13319200 0.77 MAPT (0.53) MAPTGLO1ALDH1A1LMNAHSD17B10
SCHEMBL5799369 0.77 ALDH1A1 (0.42) MAPTGLO1ALDH1A1LMNAHSD17B10
SCHEMBL5798093 0.76 ALDH1A1 (0.41) MAPTGLO1ALDH1A1LMNAHSD17B10
SCHEMBL25405030 0.75 MAPT (0.52) MAPTGLO1ALDH1A1LMNAHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8710084-B2 Tetrazolyl oxime derivative, salt thereof, and plant disease control agent NIPPON SODA CO., LTD. (JP) 2014-04-29 US disclosed
US-8710084-B2 Tetrazolyl oxime derivative, salt thereof, and plant disease control agent NIPPON SODA CO., LTD. (JP) 2014-04-29 US disclosed
EP-2404917-B1 TETRAZOLYL OXIME DERIVATIVE, SALT THEREOF, AND PLANT DISEASE CONTROL AGENT NIPPON SODA CO (JP) 2013-09-04 EP disclosed
EP-2404917-A1 TETRAZOYL OXIME DERIVATIVE, SALT THEREOF, AND PLANT DISEASE CONTROL AGENT Nippon Soda Co., Ltd. (JP) 2012-01-11 EP disclosed
US-20110313152-A1 TETRAZOLYL OXIME DERIVATIVE, SALT THEREOF, AND PLANT DISEASE NIPPON SODA CO., LTD. (JP) 2011-12-22 US disclosed
US-20110313152-A1 TETRAZOLYL OXIME DERIVATIVE, SALT THEREOF, AND PLANT DISEASE NIPPON SODA CO., LTD. (JP) 2011-12-22 US disclosed
WO-2006057503-A1 NOVEL COMPOUNDS AS AGONIST FOR PPARϜ AND PPARα, METHOD FOR PREPARATION OF THE SAME, AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME LG LIFE SCIENCES, LTD. (KR) 2006-06-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110313152-A1 TETRAZOLYL OXIME DERIVATIVE, SALT THEREOF, AND PLANT DISEASE H1-10, H1-0, OXSR1 MAPT 3320/4885GLO1 594/4885ALDH1A1 3576/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.